| Literature DB >> 29793523 |
Su Hyun Park1, Yazan Al-Ajlouni2, Joseph J Palamar2, William C Goedel2, Anthony Estreet3, Brian Elbel2, Scott E Sherman2, Dustin T Duncan2.
Abstract
BACKGROUND: Little is known about the role of financial hardship as it relates to drug use, especially among men who have sex with men (MSM). As such, this study aimed to investigate potential associations between financial hardship status and drug use among MSM.Entities:
Keywords: Alcohol; Drug use; Financial hardship; Men who have sex with men (MSM); Tobacco
Mesh:
Year: 2018 PMID: 29793523 PMCID: PMC5968620 DOI: 10.1186/s13011-018-0159-0
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Financial hardship and drug use among men who have sex with men in Paris (N = 580)
| Total | Overall usea | Any drugb | Tobacco usec | Alcohol use | Marijuana use | Inhalant nitrites use | Club drug used | |
|---|---|---|---|---|---|---|---|---|
| Total | 580 (100) | 438 (75.5) | 316 (54.5) | 250 (43.1) | 271 (46.7) | 113 (19.5) | 271 (46.7) | 68 (11.7) |
| Age | ||||||||
| 18–24 | 84 (14.5) | 70 (83.3) | 40 (47.6) | 45 (53.6) | 55 (65.5) | 23 (27.4) | 28 (33.3) | 9 (10.7) |
| 25–29 | 103 (17.8) | 83 (80.6) | 69 (67.0) | 52 (50.5) | 60 (58.3) | 35 (34.0) | 59 (57.3) | 20 (19.4) |
| 30–39 | 180 (31.0) | 137 (76.1) | 99 (55.0) | 76 (42.2) | 87 (48.3) | 26 (14.4) | 89 (49.4) | 25 (13.9) |
| 40–49 | 139 (24.0) | 104 (74.8) | 73 (52.5) | 58 (41.7) | 50 (36.0) | 24 (17.3) | 65 (46.8) | 10 (7.2) |
| ≥ 50 | 54 (9.3) | 37 (68.5) | 29 (53.7) | 16 (29.6) | 17 (31.5) | 5 (9.3) | 24 (44.4) | 4 (7.4) |
| Sexual orientation | ||||||||
| Gay | 487 (84.0) | 377 (77.4) | 276 (56.7) | 216 (44.4) | 237 (48.7) | 101 (20.7) | 236 (48.5) | 64 (13.1) |
| Bisexual | 69 (11.9) | 48 (69.6) | 30 (43.5) | 26 (37.7) | 27 (39.1) | 9 (13.0) | 25 (36.2) | 2 (2.9) |
| Born in France | ||||||||
| Yes | 450 (77.6) | 353 (78.4) | 240 (55.6) | 200 (44.4) | 224 (49.8) | 86 (19.1) | 217 (48.2) | 58 (12.9) |
| No | 113 (19.5) | 80 (70.8) | 62 (54.9) | 47 (41.6) | 45 (39.8) | 27 (23.9) | 50 (44.3) | 10 (8.9) |
| Employment status | ||||||||
| Employed | 388 (66.9) | 291 (75.0) | 208 (53.6) | 165 (42.5) | 178 (45.9) | 61 (15.7) | 186 (47.9) | 48 (12.4) |
| Unemployed | 84 (14.5) | 71 (84.5) | 57 (67.9) | 36 (42.9) | 41 (48.8) | 21 (25.0) | 49 (58.3) | 10 (11.9) |
| Student | 81 (14.0) | 65 (80.3) | 43 (53.1) | 44 (54.3) | 48 (59.3) | 31 (38.3) | 28 (34.6) | 10 (12.4) |
| Current Relationship | ||||||||
| Single | 378 (65.2) | 288 (76.2) | 201 (53.2) | 162 (42.9) | 186 (49.2) | 76 (20.1) | 168 (44.4) | 47 (12.4) |
| Relationship with a man | 172 (29.7) | 136 (79.1) | 105 (61.1) | 77 (44.8) | 78 (45.4) | 35 (20.4) | 94 (54.7) | 21 (12.2) |
| Financial Hardship | ||||||||
| Low | 297 (51.2) | 211 (71.0) | 144 (48.5) | 108 (36.4) | 134 (45.1) | 46 (15.5) | 125 (42.1) | 30 (10.1) |
| High | 264 (45.5) | 221 (83.7) | 167 (63.3) | 139 (52.7) | 135 (51.1) | 67 (25.4) | 141 (53.4) | 38 (14.4) |
Values are presented as n(%)
aIncludes cigarettes, electronic cigarettes or nicotine vapes, alcohol, marijuana, synthetic marijuana, cocaine, MDMA, ketamine, GHB/GBL, methamphetamine, heroin, prescription stimulants, prescription benzodiazepines, inhalant nitrites, other inhalants, prescription opioids, psychedelics, synthetic cathinones, and anabolic steroids
bIncludes marijuana, synthetic marijuana, cocaine, MDMA, ketamine, GHB/GBL, methamphetamine, heroin, prescription stimulants, prescription benzodiazepines, inhalant nitrites, other inhalants, prescription opioids, psychedelics, synthetic cathinones, and anabolic steroids
cIncludes cigarettes and electronic cigarettes (nicotine vapes)
dIncludes MDMA, ketamine, and GHB/GBL
Adjusted risk ratios (aRRs)a for the association between financial hardship and drug use
| Overall useb | Any Drugc | Tobacco used | Alcohol use | Marijuana use | Inhalant Nitrites use | Club drug usee | |
|---|---|---|---|---|---|---|---|
| aRR (95% CI) | aRR (95% CI) | aRR (95% CI) | aRR (95% CI) | aRR (95% CI) | aRR (95% CI) | aRR (95% CI) | |
| Financial hardship | |||||||
| Model 1 | |||||||
| Low | Referent | Referent | Referent | Referent | Referent | Referent | Referent |
| High | 1.15 (1.05, 1.27)** | 1.25 (1.07, 1.46)** | 1.45 (1.19, 1.78)** | 1.10 (0.93, 1.32) | 1.48 (1.03, 2.13)* | 1.24 (1.03, 1.50)* | 1.47 (0.91, 2.37) |
| Model 2 | |||||||
| Low | Referent | Referent | Referent | Referent | Referent | Referent | Referent |
| Medium | 1.14 (1.03, 1.26)* | 1.21 (1.02, 1.43)* | 1.37 (1.10, 1.71)** | 1.14 (0.95, 1.37) | 1.37 (0.92, 2.03) | 1.18 (0.96, 1.45) | 1.46 (0.87, 2.44) |
| High | 1.19 (1.06, 1.34)** | 1.37 (1.12, 1.67)** | 1.67 (1.30, 2.16)** | 1.01 (0.77, 1.32) | 1.80 (1.13, 2.85)* | 1.40 (1.11, 1.78)** | 1.48 (0.75, 2.92) |
| Test for trend | p = 0.01 | ||||||
aRR adjusted risk ratio, CI Confidence Intervals
aAdjusted for age, sexual orientation, origin (born in France), employment and relationship status
bIncludes cigarettes, electronic cigarettes or nicotine vapes, alcohol, marijuana, synthetic marijuana, cocaine, MDMA, ketamine, GHB/GBL, methamphetamine, heroin, prescription stimulants, prescription benzodiazepines, inhalant nitrites, other inhalants, prescription opioids, psychedelics, synthetic cathinones, and anabolic steroids
cIncludes marijuana, synthetic marijuana, cocaine, MDMA, ketamine, GHB/GBL, methamphetamine, heroin, prescription stimulants, prescription benzodiazepines, inhalant nitrites, other inhalants, prescription opioids, psychedelics, synthetic cathinones, and anabolic steroids
dIncludes cigarettes and electronic cigarettes (nicotine vapes)
eIncludes MDMA, ketamine and GHB/GBL
Model 1: high financial hardship (Somewhat difficult; Very difficult; and Extremely difficult) and low financial hardship (Not at all difficult and Not very difficult)
Model 2: high financial hardship (very difficult and extremely difficult), somewhat difficult, and low (not at all and not very difficult)
*p < 0.05; **p < 0.01